Gastrointestinal aspects of Peutz-Jeghers syndrome

A R Latchford1, S K Clark1

  • 1Polyposis Registry, St Mark's Hospital, Harrow, UK; Department of Surgery and Cancer, Imperial College, London, UK.

Insights

Peutz-Jeghers syndrome (PJS) management involves addressing cancer risks and polyp complications like intussusception. Clinical recommendations for gastrointestinal tract surveillance in PJS patients are discussed, highlighting knowledge gaps.

Area of Science:

  • Gastroenterology
  • Clinical Genetics
  • Oncology

Background:

  • Peutz-Jeghers syndrome (PJS) presents significant clinical challenges.
  • Key issues include long-term cancer risk and managing gastrointestinal polyp complications, notably intussusception.
  • The rarity of PJS limits the evidence base for clinical recommendations.

Purpose of the Study:

  • To explore controversies surrounding PJ polyps, cancer development, and cancer risk in PJS.
  • To provide an overview of clinical data and management recommendations for the gastrointestinal tract in PJS.
  • To identify knowledge gaps requiring further research.

Main Methods:

  • Review of existing clinical data and literature on Peutz-Jeghers syndrome.
  • Analysis of controversies in the relationship between PJ polyps and cancer.
  • Synthesis of current recommendations for gastrointestinal management and surveillance.

Main Results:

  • Clinical management of PJS gastrointestinal tract is complex due to cancer risk and polyp complications.
  • Evidence for recommendations is limited, and controversies regarding PJ polyps and cancer persist.
  • Current recommendations focus on clinical management and surveillance strategies for the GI tract.

Conclusions:

  • Effective management of Peutz-Jeghers syndrome requires addressing both cancer surveillance and polyp-related complications.
  • Further research is crucial to resolve controversies and strengthen the evidence base for PJS clinical guidelines.
  • Addressing identified knowledge gaps will improve patient outcomes and clinical care for PJS patients.

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
284
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
495
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
273
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
956
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
569
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
227